Market revenue in 2023 | USD 4,134.4 million |
Market revenue in 2030 | USD 5,982.9 million |
Growth rate | 5.4% (CAGR from 2023 to 2030) |
Largest segment | Covid-19 testing |
Fastest growing segment | Glucose testing |
Historical data | 2018 - 2022 |
Base year | 2023 |
Forecast period | 2024 - 2030 |
Quantitative units | Revenue in USD million |
Market segmentation | Glucose testing, A1C testing, Direct LDL testing, Lipid panel testing, Prostate-specific antigen testing, COVID-19 testing, BUN testing, Vitamin D testing, Thyroid-stimulating hormone testing, Serum Nicotine / Cotinine testing, High sensitivity CRP testing, Testosterone testing, ALT testing, Cortisol testing, Creatinine testing, AST testing, Other blood tests |
Key market players worldwide | Abbott Laboratories, Roche Holding AG ADR, Bio-Rad Laboratories Inc, BioMerieux SA, Quest Diagnostics Inc, Biomerica Inc, Becton Dickinson & Co, Siemens Healthineers AG ADR, Danaher Corp, Trinity Biotech PLC ADR |
No credit card required*
Name | Profile | # Employees | HQ | Website |
---|
The databook is designed to serve as a comprehensive guide to navigating this sector. The databook focuses on market statistics denoted in the form of revenue and y-o-y growth and CAGR across the globe and regions. A detailed competitive and opportunity analyses related to blood testing market will help companies and investors design strategic landscapes.
Covid-19 testing was the largest segment with a revenue share of 18.85% in 2023. Horizon Databook has segmented the Germany blood testing market based on glucose testing, a1c testing, direct ldl testing, lipid panel testing, prostate-specific antigen testing, covid-19 testing, bun testing, vitamin d testing, thyroid-stimulating hormone testing, serum nicotine / cotinine testing, high sensitivity crp testing, testosterone testing, alt testing, cortisol testing, creatinine testing, ast testing, other blood tests covering the revenue growth of each sub-segment from 2018 to 2030.
Germany is the largest contributor to Europe blood testing market. In 2020, Germany accounted for the highest market share owing to high healthcare expenditure, easy availability of products, and presence of well-equipped laboratories.
New market entrants are strategically collaborating with various companies to enhance rapid diagnostic technology, which is anticipated to boost the market growth in Germany during the forecast period.
For instance, in August 2019, Expedeon AG signed a commercial agreement with Sona Nanotech, Inc. As per the agreement, Expedeon will be providing its bioconjugation technologies, gold nanoparticle, and expertise, while Sona Nanotech, Inc. will be offering its lateral flow developing services.
Horizon Databook provides a detailed overview of country-level data and insights on the Germany blood testing market , including forecasts for subscribers. This country databook contains high-level insights into Germany blood testing market from 2018 to 2030, including revenue numbers, major trends, and company profiles.
Sign up and get instant basic access to databook, upgrade
when ready, or enjoy our
free plan indefinitely.
Included in Horizon account